Psychiatry & Neurology Doctors in Ft. Worth, TX Accepting Medicare
1 Psychiatry & Neurology doctors found. Showing 1 - 1
 Dr. Lisa Diane Fairweather, D.O. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5601 Bridge St., #324, Ft. Worth, TX 76112 Phone: 817-457-4646 Fax: 817-492-7135 |
News Archive
A high number of lifetime sexual partners raises cancer risk
A new study seems to reinforce traditional common sense and good morals: people who play around with sex tend to have a higher risk of cancer. The study published online in the journal BMJ Sexual and Reproductive Health in February 2020 shows that having ten or more sex partners increases the risk of cancer in both men and women. And in women, this pattern of sexual behavior increases the chances of a chronic debilitating illness.
Prehabilitation for surgery patients may help reduce length of hospital stay, overall costs
An inexpensive program to help surgery patients get physically and mentally ready for their upcoming operation may help reduce overall costs and get them home faster, according to new research involving hundreds of patients in 21 hospitals across Michigan.
Roche Applied Science announces availability of new CIM-Plate 16 for their xCELLigence System
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument.
Ocean Nutrition Canada purchases Alicorp fish oil refining plant
Ocean Nutrition Canada (ONC) the world's largest Omega-3 ingredient supplier, today announced its acquisition of a fish oil refining plant in Piura, Peru. With the purchase of the plant, ONC will now offer its customers a completely integrated supply chain, from primary processing through to finished ingredient.
Liquidia Technologies completes $20M Series C financing round
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
› Verified 5 days ago